Skip to main content

GM Salmon Goes Commercial

Environment Canada allows production of genetically modified salmon eggs at commercial levels.

Written byAbby Olena, PhD
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

Young Atlantic salmon FLICKR, U.S. FISH AND WILDLIFE SERVICEAs controversy swirls over genetic engineering of foods, a genetically modified (GM) animal is one step closer to becoming a main course. AquaBounty Technologies, the firm that makes genetically modified salmon that grow twice as fast as non-GM salmon, has been given permission by Environment Canada to produce its GM fish eggs on a commercial scale in its Prince Edward Island research facility, according to a press release.

The GM salmon, called AquAdvantage, are Atlantic salmon (Salmo salar) with an extra gene from Chinook salmon (Oncorhynchus tshawytscha) engineered into their genomes. The terms of the decision attempted to carefully control the GM eggs, which are all-female and sterile, according to the press release. “There are strict measures in place to prevent the release of this fish into the food chain,” an Environment Canada spokesman wrote in an e-mail to The Guardian.

GM salmon is still not approved for human consumption in Canada. “It’s only the status of the facility moving from research and development to essentially a facility that could be used for commercial purposes,” AquaBounty CEO Ron Stotish told The Canadian Press. “We would be regulated as a novel food in Canada ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo